Weight Loss Drugs Linked to 7% Increased Hair Loss Risk in Genetically Susceptible Men
Source Summary
A new study finds that men genetically predisposed to common male pattern baldness face a 7% increased risk of hair loss when using weight loss medications such as Ozempic, Wegovy, and Zepbound. These drugs are primarily prescribed for type 2 diabetes and obesity treatment.
Why it matters
The finding identifies a potential side effect of increasingly popular weight loss medications that millions of patients use, informing treatment decisions for those with genetic predisposition to hair loss.
